Impact of Adding Integrated Neuromuscular Inhibition Technique to Postural Correction Exercises in Patients With Cervicogenic Headache
CGH
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
this study will be conducted to investigate the impact of adding integrated neuromuscular inhibition technique to postural correction exercises in patients with cervicogenic headache
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2025
CompletedFirst Posted
Study publicly available on registry
July 25, 2025
CompletedStudy Start
First participant enrolled
July 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2026
CompletedJuly 25, 2025
July 1, 2025
7 months
July 18, 2025
July 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
pain intensity
visual analogue scale will be used to asses pain intensity which patient will be instructed to put point on line from no pain to tolerable pain. The scale consists of a line, usually 100 mm long, ranging from no pain or discomfort (zero) , to the worst pain that could possibly feel .
up to six weeks
headache disability
The Headache spesific Disability Questionnaire was used to assess headcahe disability. it is a self-administered scale with 9 items that assesses pain intensity, work or school disruptions, and the effect on recreational activities in individuals with headache complaints. Higher scores reflect greater impairment.
up to 6 weeks
Secondary Outcomes (5)
pressure pain threshold
up to 6 weeks
cervical range of motion
up to 6 weeks
headache frequency
up to six weeks
medication intake
up to six weeks
headache duration
up to six weeks
Study Arms (2)
Integrated Neuromuscular Inhibition Technique
EXPERIMENTALForty-five patients will receive integrated neuromuscular inhibition technique plus postural correction exercises three times a week for six weeks
Postural Correction Exercise
ACTIVE COMPARATORForty-five patients will receive postural correction exercises three times a week for six weeks
Interventions
Patients will receive integrated neuromuscular inhibition technique in the form of intermittent ischemic compression, strain counterstrain, and muscle energy technique plus postural correction exercises
The exercise program will be in the form of stretching exercises for the sternocleidomastoids (SCM), the scalenes, and upper fibers of trapezius; strengthening isometric exercises for the neck flexors, extensors, lateral flexors, and neck rotators; and postural correction exercises.
Eligibility Criteria
You may qualify if:
- to 60 years old patient with unilaterally of the head pain
- pain triggered by external pressure over the upper cervical joints (c1-c3)
- pain elicited by the neck movements, and/or sustained awkward positions with reduced neck ROM
- headache intensity pain score of at least 20mm on the Visual analogue scale (VAS)
- headache frequency of at least once a week for at least 3 months
- minimum neck disability index score of 10 points or greater
You may not qualify if:
- Migraine, tension- type headache, tumor, osteoporosis, fracture, rheumatoid arthritis and metabolic diseases.
- Prolonged history of steroid use.
- Resting blood pressure greater than 140/90 mmhg.
- cervical spinal stenosis, diminished sensation and central nervous system involvement,
- previous
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- opaque sealed envelope
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator : alshaymaa shaaban abd el azeim
Study Record Dates
First Submitted
July 18, 2025
First Posted
July 25, 2025
Study Start
July 30, 2025
Primary Completion
February 25, 2026
Study Completion
February 25, 2026
Last Updated
July 25, 2025
Record last verified: 2025-07